Search

Author/Creator Christner, Susan M.

1. Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627). Issue 7 (10th March 2015)

Authors:
Lassman, Andrew B.; Pugh, Stephanie L.; Gilbert, Mark R.; Aldape, Kenneth D.; Geinoz, Sandrine; Beumer, Jan H.; Christner, Susan M.; Komaki, Ritsuko; DeAngelis, Lisa M.; Gaur, Rakesh; Youssef, Emad; Wagner, Henry; Won, Minhee; Mehta, Minesh P.
Journal:
Neuro-oncology
Issue:
Volume 17:Issue 7(2015:Jul.)
Page Start:
992
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Human hepatocyte assessment of imatinib drug–drug interactions – complexities in clinical translation. (19th September 2015)

Authors:
Beumer, Jan H.; Pillai, Venkateswaran C.; Parise, Robert A.; Christner, Susan M.; Kiesel, Brian F.; Rudek, Michelle A.; Venkataramanan, Raman
Journal:
British journal of clinical pharmacology
Issue:
Volume 80:Number 5(2015:Nov.)
Page Start:
1097
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemia. Issue 11 (2nd November 2018)

Authors:
Redner, Robert L.; Beumer, Jan H.; Kropf, Patricia; Agha, Mounzer; Boyiadzis, Michael; Dorritie, Kathleen; Farah, Rafic; Hou, Jing-Zhao; Im, Annie; Lim, Seah H.; Raptis, Anastasios; Sehgal, Alison; Christner, Susan M.; Normolle, Daniel; Johnson, Daniel E.
Journal:
Leukemia & lymphoma
Issue:
Volume 59:Issue 11(2018)
Page Start:
2595
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Potential interactions between HIV drugs, ritonavir and efavirenz and anticancer drug, nilotinib—a study in primary cultures of human hepatocytes that is applicable to HIV patients with cancer. (27th May 2014)

Authors:
Pillai, Venkateswaran C.; Parise, Robert A.; Christner, Susan M.; Rudek, Michelle A.; Beumer, Jan H.; Venkataramanan, Raman
Journal:
Journal of clinical pharmacology
Issue:
Volume 54:Number 11(2014:Nov.)
Page Start:
1272
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Poly (ADP) ribose polymerase enzyme inhibitor, veliparib, potentiates chemotherapy and radiation in vitro and in vivo in small cell lung cancer. (13th August 2014)

Authors:
Owonikoko, Taofeek K.; Zhang, Guojing; Deng, Xingming; Rossi, Michael R.; Switchenko, Jeffrey M.; Doho, Gregory H.; Chen, Zhengjia; Kim, Sungjin; Strychor, Sandy; Christner, Susan M.; Beumer, Jan; Li, Chunyang; Yue, Ping; Chen, Alice; Sica, Gabriel L.; Ramalingam, Suresh S.; Kowalski, Jeanne; Khu...
Journal:
Cancer medicine
Issue:
Volume 3:Number 6(2014:Dec.)
Page Start:
1579
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. An Automated Homogeneous Immunoassay for Quantitating Imatinib Concentrations in Plasma. Issue 4 (August 2015)

Authors:
Beumer, Jan H.; Kozo, Daniel; Harney, Rebecca L.; Baldasano, Caitlin N.; Jarrah, Justin; Christner, Susan M.; Parise, Robert; Baburina, Irina; Courtney, Jodi B.; Salamone, Salvatore J.
Journal:
Therapeutic drug monitoring
Issue:
Volume 37:Issue 4(2015:Aug.)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗